In this study, we demonstrate that ENT4 is transcriptionally activated by both isoforms of EWS/WT1 and is highly expressed in DSRCT, implicating ENT4 as a potential therapeutic target. The gene discussed is WT1; the disease is desmoplastic small round cell tumor.